Afstyla recombinant and Linagliptin and Metformin Extended-Release Tablets

• Generic Name: antihemophilic factor
• Dosage Forms: n.a.
• Other Brand Names: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur

Afstyla is a naturally occurring protein in the blood that helps blood to clot. A lack of antihemophilic factor VIII is the cause of hemophilia A. Recombinant this medicine works by temporarily raising levels of factor VIII in the blood to aid in clotting.

Recombinant Afstyla is used to treat or prevent bleeding episodes in adults and children with hemophilia A. It is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage.

Recombinant Afstyla is not for use in people with von Willebrand disease.

Recombinant Afstyla may also be used for purposes not listed in this medication guide.

• Generic Name: linagliptin / metformin
• Dosage Forms: n.a.
• Other Brand Names: Jentadueto, Jentadueto XR

• It is used to lower blood sugar in patients with high blood sugar (diabetes).